In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 3140020)

Published in Horm Cancer on June 01, 2010

Authors

Leo F Doherty1, Jason G Bromer, Yuping Zhou, Tamir S Aldad, Hugh S Taylor

Author Affiliations

1: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.

Articles citing this

EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51

Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect (2011) 1.71

Biosensor zebrafish provide new insights into potential health effects of environmental estrogens. Environ Health Perspect (2012) 1.52

Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun (2011) 1.43

Epigenetic effects of environmental chemicals bisphenol A and phthalates. Int J Mol Sci (2012) 1.23

LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta (2015) 1.21

Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia (2013) 1.07

Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol Biol (2014) 1.01

Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res (2014) 0.99

The intersection of neurotoxicology and endocrine disruption. Neurotoxicology (2012) 0.96

The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals. Endocrinology (2015) 0.94

Epigenetic regulation of estrogen signaling in breast cancer. Epigenetics (2013) 0.94

Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology (2014) 0.92

High intake of dietary sugar enhances bisphenol A (BPA) disruption and reveals ribosome-mediated pathways of toxicity. Genetics (2014) 0.91

Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia (2013) 0.90

Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer (2014) 0.90

Current concepts in neuroendocrine disruption. Gen Comp Endocrinol (2014) 0.87

Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86

Early-life Exposure to Endocrine Disrupting Chemicals and Later-life Health Outcomes: An Epigenetic Bridge? Aging Dis (2014) 0.85

Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol (2015) 0.85

Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention. Biomed Res Int (2015) 0.84

Bisphenol A and phthalate endocrine disruption of parental and social behaviors. Front Neurosci (2015) 0.84

Effect of in utero exposure to diethylstilbestrol on lumbar and femoral bone, articular cartilage, and the intervertebral disc in male and female adult mice progeny with and without swimming exercise. Arthritis Res Ther (2012) 0.84

Multigenerational and transgenerational effects of endocrine disrupting chemicals: A role for altered epigenetic regulation? Semin Cell Dev Biol (2015) 0.83

Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants. Front Genet (2012) 0.82

Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programming. Carcinogenesis (2012) 0.82

Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease. Prog Biophys Mol Biol (2015) 0.82

Targeted genome-wide methylation and gene expression analyses reveal signaling pathways involved in ovarian dysfunction after developmental EDC exposure in rats. Biol Reprod (2013) 0.81

Chromatin modifications during repair of environmental exposure-induced DNA damage: a potential mechanism for stable epigenetic alterations. Environ Mol Mutagen (2013) 0.81

Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer. Reprod Toxicol (2014) 0.79

Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells. PLoS One (2015) 0.78

Bisphenol A Effects on Mammalian Oogenesis and Epigenetic Integrity of Oocytes: A Case Study Exploring Risks of Endocrine Disrupting Chemicals. Biomed Res Int (2015) 0.78

Environmental-stress-induced Chromatin Regulation and its Heritability. J Carcinog Mutagen (2014) 0.78

BPA-Induced Deregulation Of Epigenetic Patterns: Effects On Female Zebrafish Reproduction. Sci Rep (2016) 0.78

Bisphenol A and hormone-associated cancers: current progress and perspectives. Medicine (Baltimore) (2015) 0.78

Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property? Lab Anim Res (2011) 0.78

The Impact of External Factors on the Epigenome: In Utero and over Lifetime. Biomed Res Int (2016) 0.77

Bisphenol A disrupts transcription and decreases viability in aging vascular endothelial cells. Int J Mol Sci (2014) 0.77

Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors. Mol Endocrinol (2015) 0.77

Epigenetic Regulation of Non-Lymphoid Cells by Bisphenol A, a Model Endocrine Disrupter: Potential Implications for Immunoregulation. Front Endocrinol (Lausanne) (2015) 0.77

Exposure to diethylstilbestrol during pregnancy modulates microRNA expression profile in mothers and fetuses reflecting oncogenic and immunological changes. Mol Pharmacol (2015) 0.76

Homeostatic imbalance and colon cancer: the dynamic epigenetic interplay of inflammation, environmental toxins, and chemopreventive plant compounds. Front Oncol (2012) 0.76

Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studies. Reprod Toxicol (2015) 0.75

Chemical exposure as etiology in developmental origin of adult onset human cancer. Front Pharmacol (2011) 0.75

A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling. Sci Rep (2016) 0.75

Epigenome-wide DNA methylation analysis implicates neuronal and inflammatory signaling pathways in adult murine hepatic tumorigenesis following perinatal exposure to bisphenol A. Environ Mol Mutagen (2016) 0.75

Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure. FASEB J (2016) 0.75

Low-Dose Bisphenol A Exposure: A Seemingly Instigating Carcinogenic Effect on Breast Cancer. Adv Sci (Weinh) (2016) 0.75

Interaction between bisphenol A and dietary sugar affects global gene transcription in Drosophila melanogaster. Genom Data (2014) 0.75

'Omics' and endocrine-disrupting chemicals - new paths forward. Nat Rev Endocrinol (2017) 0.75

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05

Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (2002) 24.31

The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30

Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature (2000) 18.26

Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A (2003) 13.68

The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev (2002) 13.08

A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47

Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60

Human exposure to bisphenol A (BPA). Reprod Toxicol (2007) 6.91

Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res (2008) 6.46

Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology (1993) 6.20

Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect (2002) 5.24

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol (2005) 4.24

Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science (2005) 3.80

Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod (2002) 3.45

Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem (1973) 2.58

Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology (2006) 2.35

Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect (2007) 2.29

Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology (2005) 2.14

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin Cancer Res (2006) 2.10

Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res (1980) 2.03

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia (2004) 1.92

Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2006) 1.92

Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.91

Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2006) 1.90

Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol Reprod (2005) 1.79

The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene (2005) 1.73

In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system. FASEB J (2000) 1.62

Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol (1998) 1.58

Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med (1984) 1.58

Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res (2006) 1.54

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS One (2009) 1.52

Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J (2010) 1.48

Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol (2002) 1.45

The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Neoplasia (2005) 1.42

Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology (2009) 1.25

Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control (2002) 1.20

Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20

Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J (2006) 1.11

Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol (2005) 1.10

Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA (1993) 1.05

Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol (1996) 1.01

Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life. Mol Carcinog (2007) 1.01

Mechanism of Polycomb group gene silencing. Cold Spring Harb Symp Quant Biol (2004) 0.97

Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res (1987) 0.96

Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high-fat diets. J Natl Cancer Inst (1990) 0.89

Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology (1988) 0.81

Articles by these authors

Long-term effects of hormone therapy on skin rigidity and wrinkles. Fertil Steril (2005) 2.77

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48

Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells (2007) 2.16

Endocrine regulation of HOX genes. Endocr Rev (2006) 2.04

Differential effects of menopausal therapies on the endometrium. Menopause (2014) 1.98

Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61

Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol (2002) 1.53

Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril (2006) 1.52

Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci (2008) 1.49

Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J (2010) 1.48

Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update (2010) 1.42

Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J Cell Mol Med (2011) 1.27

Inflammation in reproductive disorders. Reprod Sci (2009) 1.26

Transcriptional repression of peri-implantation EMX2 expression in mammalian reproduction by HOXA10. Mol Cell Biol (2003) 1.26

Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.26

Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology (2009) 1.25

Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod (2008) 1.25

Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reprod Sci (2007) 1.24

Regulation of insulin-like growth factor binding protein-1 promoter activity by FKHR and HOXA10 in primate endometrial cells. Biol Reprod (2003) 1.22

Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril (2008) 1.21

HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol Ther (2004) 1.18

HOXA10, Pbx2, and Meis1 protein expression in the human endometrium: formation of multimeric complexes on HOXA10 target genes. J Clin Endocrinol Metab (2004) 1.18

The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15

Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am (2012) 1.12

Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J (2006) 1.11

Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther (2011) 1.09

Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril (2006) 1.08

Failure of the stem cell niche rather than loss of oocyte stem cells in the aging ovary. Aging (Albany NY) (2010) 1.07

HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. J Clin Invest (2008) 1.07

The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol (2009) 1.06

Insurance coverage and in vitro fertilization outcomes: a U.S. perspective. Fertil Steril (2010) 1.05

A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med (2012) 1.04

Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance. J Physiol (2010) 1.03

The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med (2009) 1.03

Progesterone increases plasma volume independent of estradiol. J Appl Physiol (1985) (2005) 1.03

Fetal radiofrequency radiation exposure from 800-1900 mhz-rated cellular telephones affects neurodevelopment and behavior in mice. Sci Rep (2012) 1.02

Effects of estrogen and progesterone administration on extracellular fluid. J Appl Physiol (1985) (2003) 1.02

The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J Assist Reprod Genet (2010) 1.02

Gene expression profiling reveals putative HOXA10 downstream targets in the periimplantation mouse uterus. Reprod Sci (2008) 1.02

A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol (2004) 1.02

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02

The role of HOX genes in human implantation. Ann N Y Acad Sci (2004) 1.00

Defining the proliferative phase endometrial defect. Fertil Steril (2008) 1.00

Molecular regulation of mullerian development by Hox genes. Ann N Y Acad Sci (2004) 1.00

Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99

Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev (2012) 0.99

Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci (2010) 0.99

Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol (2005) 0.99

HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium. J Clin Endocrinol Metab (2002) 0.98

HOX genes in implantation. Semin Reprod Med (2007) 0.98

Hydrosalpinx fluid diminishes endometrial cell HOXA10 expression. Fertil Steril (2002) 0.98

Differential cell-specific modulation of HOXA10 by estrogen and specificity protein 1 response elements. J Clin Endocrinol Metab (2007) 0.96

Stem cells and female reproduction. Reprod Sci (2009) 0.96

Pleiotropic effects of Hoxa10 on the functional development of peri-implantation endometrium. Mol Reprod Dev (2004) 0.95

MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metab (2011) 0.95

Cigarette smoke increases progesterone receptor and homeobox A10 expression in human endometrium and endometrial cells: a potential role in the decreased prevalence of endometrial pathology in smokers. Biol Reprod (2011) 0.94

EMX2 gene expression in the female reproductive tract and aberrant expression in the endometrium of patients with endometriosis. J Clin Endocrinol Metab (2004) 0.94

Hormonal regulation of implantation. Obstet Gynecol Clin North Am (2004) 0.93

Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol (2010) 0.93

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril (2004) 0.93

Aromatase inhibitor for treatment of a recurrent abdominal wall endometrioma in a postmenopausal woman. Fertil Steril (2009) 0.93

Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93

GnRH antagonists may affect endometrial receptivity. Fertil Steril (2008) 0.93

Oestrogen effects on urine concentrating response in young women. J Physiol (2003) 0.93

Endometrial polyps affect uterine receptivity. Fertil Steril (2011) 0.92

A novel mutation of HOXA13 in a family with hand-foot-genital syndrome and the role of polyalanine expansions in the spectrum of Müllerian fusion anomalies. Fertil Steril (2009) 0.92

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success. Fertil Steril (2010) 0.91

Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci (2011) 0.91

Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod (2010) 0.91

Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3. J Clin Endocrinol Metab (2010) 0.91

Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology (2011) 0.90

Methoxychlor disrupts uterine Hoxa10 gene expression. Endocrinology (2005) 0.90

Mechanisms contributing to low orthostatic tolerance in women: the influence of oestradiol. J Physiol (2013) 0.90

Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome. J Physiol (2011) 0.90

HOXC and HOXD gene expression in human endometrium: lack of redundancy with HOXA paralogs. Biol Reprod (2003) 0.89

In vivo gene transfer of lefty leads to implantation failure in mice. Hum Reprod (2005) 0.89

Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril (2011) 0.88

HOXA10 expression in endometrial adenocarcinoma. Tumour Biol (2005) 0.88

HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium. Biol Reprod (2010) 0.88

Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus. Reprod Toxicol (2010) 0.87

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol (2012) 0.86

Calpain5 expression is decreased in endometriosis and regulated by HOXA10 in human endometrial cells. Mol Hum Reprod (2008) 0.86

Reproductive tract gene transfer. Fertil Steril (2003) 0.86

Molecular mechanisms of treatment resistance in endometriosis: the role of progesterone-hox gene interactions. Semin Reprod Med (2010) 0.86

Regulation of tryptophan 2,3-dioxygenase by HOXA10 enhances embryo viability through serotonin signaling. Am J Physiol Endocrinol Metab (2010) 0.86

Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls. Med Sci Sports Exerc (2010) 0.85

Stem cells and reproduction. Curr Opin Obstet Gynecol (2010) 0.85

FKBP4 is regulated by HOXA10 during decidualization and in endometriosis. Reproduction (2012) 0.84

Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod (2003) 0.84

Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology (2014) 0.84

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83

Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease. J Cell Mol Med (2014) 0.83

Thrombin and interleukin-1beta regulate HOXA10 expression in human term decidual cells: implications for preterm labor. J Clin Endocrinol Metab (2006) 0.83

Thrombin and interleukin-1beta decrease HOX gene expression in human first trimester decidual cells: implications for pregnancy loss. Mol Hum Reprod (2009) 0.83